CoChat
Sign Up
Cited by 69

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity

Gonzalez, Esperanza, van Liempd, Sebastiaan, Conde-Vancells, Javier, Gutierrez-de Juan, Virginia, Perez-Cormenzana, Miriam, Mayo, Rebeca, Berisa, Agustin, Alonso, Cristina, Marquez, Cesar A., Barr, Jonathan, Lu, Shelly C., Mato, Jose M., Falcon-Perez, Juan M.·2012·Metabolomics
DOI 10.1007/s11306-011-0329-9PMC PMC3490499
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11306-011-0329-9

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 1 references

Research works printed but not linked: 49

  1. Arai, K., Lee, K., Berthiaume, F., Tompkins, R. G., & Yarmush, M. L. (2001). Intrahepatic amino acid and glucose metabolism in a d-galactosamine-induced rat liver failure model. Hepatology, 34, 360–371. · DOI
  2. Barr, J., Vazquez-Chantada, M., Alonso, C., Perez-Cormenzana, M., Mayo, R., Galan, A., et al. (2010). Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. Journal of Proteome Research, 9, 4501–4512. · DOI
  3. Boelsterli, U. A., & Lim, P. L. (2007). Mitochondrial abnormalities—a link to idiosyncratic drug hepatotoxicity? Toxicology and Applied Pharmacology, 220, 92–107. · DOI
  4. Brindle, J. T., Antti, H., Holmes, E., Tranter, G., Nicholson, J. K., Bethell, H. W., et al. (2002). Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nature Medicine, 8, 1439–1444. · DOI
  5. Cabrero, C., Duce, A. M., Ortiz, P., Alemany, S., & Mato, J. M. (1988). Specific loss of the high-molecular-weight form of S-adenosyl-l-methionine synthetase in human liver cirrhosis. Hepatology, 8, 1530–1534. · DOI
  6. Chan, E. C., Yap, S. L., Lau, A. J., Leow, P. C., Toh, D. F., & Koh, H. L. (2007). Ultra-performance liquid chromatography/time-of-flight mass spectrometry based metabolomics of raw and steamed Panax notoginseng. Rapid Communications in Mass Spectrometry, 21, 519–528. · DOI
  7. Chen, C., Gonzalez, F. J., & Idle, J. R. (2007). LC-MS-based metabolomics in drug metabolism. Drug Metabolism Reviews, 39, 581–597. · DOI
  8. Clarke, C. J., & Haselden, J. N. (2008). Metabolic profiling as a tool for understanding mechanisms of toxicity. Toxicologic Pathology, 36, 140–147. · DOI
  9. Coen, M. (2010). A metabonomic approach for mechanistic exploration of pre-clinical toxicology. Toxicology, 278, 326–340. · DOI
  10. Coen, M., Hong, Y. S., Clayton, T. A., Rohde, C. M., Pearce, J. T., Reily, M. D., et al. (2007). The mechanism of galactosamine toxicity revisited; a metabonomic study. Journal of Proteome Research, 6, 2711–2719. · DOI
  11. Coen, M., Want, E. J., Clayton, T. A., Rhode, C. M., Hong, Y. S., Keun, H. C., et al. (2009). Mechanistic aspects and novel biomarkers of responder and non-responder phenotypes in galactosamine-induced hepatitis. Journal of Proteome Research, 8, 5175–5187. · DOI
  12. Dan, Y. Y., & Yeoh, G. C. (2008). Liver stem cells: A scientific and clinical perspective. Journal of Gastroenterology and Hepatology, 23, 687–698. · DOI
  13. Decker, K., & Keppler, D. (1972). Galactosamine induced liver injury. Progress in Liver Diseases, 4, 183–199.
  14. Duarte, I. F., Stanley, E. G., Holmes, E., Lindon, J. C., Gil, A. M., Tang, H., et al. (2005). Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Analytical Chemistry, 77, 5570–5578. · DOI
  15. El-Mofty, S. K., Scrutton, M. C., Serroni, A., Nicolini, C., & Farber, J. L. (1975). Early, reversible plasma membrane injury in galactosamine-induced liver cell death. The American Journal of Pathology, 79, 579–596.
  16. Feng, B., Wu, S., Lv, S., Liu, F., Chen, H., Yan, X., et al. (2007). Metabolic profiling analysis of a d-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. Journal of Proteome Research, 6, 2161–2167. · DOI
  17. Fernie, A. R., Trethewey, R. N., Krotzky, A. J., & Willmitzer, L. (2004). Metabolite profiling: From diagnostics to systems biology. Nature Reviews Molecular Cell Biology, 5, 763–769. · DOI
  18. Fox, L. M., Cox, D. G., Lockridge, J. L., Wang, X., Chen, X., Scharf, L., et al. (2009). Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biology, 7, e1000228. · DOI
  19. Gomez-Lechon, M. J., Castell, J. V., & Donato, M. T. (2008). An update on metabolism studies using human hepatocytes in primary culture. Expert Opinion on Drug Metabolism, 4, 837–854. · DOI
  20. Kaplowitz, N. (2001). Drug-induced liver disorders: Implications for drug development and regulation. Drug Safety, 24, 483–490. · DOI
  21. Keppler, D., Lesch, R., Reutter, W., & Decker, K. (1968). Experimental hepatitis induced by d-galactosamine. Experimental and Molecular Pathology, 9, 279–290. · DOI
  22. Kitazawa, T., Tsujimoto, T., Kawaratani, H., & Fukui, H. (2009). Therapeutic approach to regulate innate immune response by Toll-like receptor 4 antagonist E5564 in rats with D-galactosamine-induced acute severe liver injury. Journal of Gastroenterology and Hepatology, 24, 1089–1094. · DOI
  23. Koff, R. S., Fitts, J. J., Sabesin, S. M., & Zimmerman, H. J. (1971). d-galactosamine hepatotoxicity II. Mechanism of fatty liver production. Proceedings of the Society for Experimental Biology and Medicine, 138, 89–92. · DOI
  24. Komano, T., Egashira, Y., & Sanada, H. (2008). l-Gln and l-Ser suppress the d-galactosamine-induced IL-18 expression and hepatitis. Biochemical and Biophysical Research Communications, 372, 688–690. · DOI
  25. Kushnir, M. M., Rockwood, A. L., Bergquist, J. (2009). Liquid chromatography-tandem mass spectrometry applications in endocrinology. Mass Spectrometry Reviews, 29, 480–502. · DOI
  26. Lin, H. M., Barnett, M. P., Roy, N. C., Joyce, N. I., Zhu, S., Armstrong, K., et al. (2010). Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn’s disease. Journal of Proteome Research, 9, 1965–1975. · DOI
  27. Lott, J. A., & Landesman, P. W. (1984). The enzymology of skeletal muscle disorders. Critical Reviews in Clinical Laboratory Sciences, 20, 153–190. · DOI
  28. Lutz, U., Lutz, R. W., & Lutz, W. K. (2006). Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender. Analytical Chemistry, 78, 4564–4571. · DOI
  29. Lv, S., Wei, L., Wang, J. H., Wang, J. Y., & Liu, F. (2007). Identification of novel molecular candidates for acute liver failure in plasma of BALB/c murine model. Journal of Proteome Research, 6, 2746–2752. · DOI
  30. Maezono, K., Kajiwara, K., Mawatari, K., Shinkai, A., Torii, K., & Maki, T. (1996). Alanine protects liver from injury caused by F-galactosamine and CCl4. Hepatology, 24, 185–191.
  31. Major, H. J., Williams, R., Wilson, A. J., & Wilson, I. D. (2006). A metabonomic analysis of plasma from Zucker rat strains using gas chromatography/mass spectrometry and pattern recognition. Rapid Communications in Mass Spectrometry, 20, 3295–3302. · DOI
  32. Mato, J. M., Martinez-Chantar, M. L., & Lu, S. C. (2008). Methionine metabolism and liver disease. Annual Review of Nutrition, 28, 273–293. · DOI
  33. Medline, A., Schaffner, F., & Popper, H. (1970). Ultrastructural features in galactosamine-induced hepatitis. Experimental and Molecular Pathology, 12, 201–211. · DOI
  34. Miller, T. J., Knapton, A., Adeyemo, O., Noory, L., Weaver, J., & Hanig, J. P. (2008). Cytochrome c: A non-invasive biomarker of drug-induced liver injury. Journal of Applied Toxicology, 28, 815–828. · DOI
  35. Miyahara, M., Enzan, H., Shiraishi, N., Kawase, M., Yamamoto, M., Hara, H., et al. (1982). Mitochondrial damage in galactosamine-induced liver intoxication in rats. Biochimica et Biophysica Acta, 714, 505–515. · DOI
  36. Newsome, P. N., Plevris, J. N., Nelson, L. J., & Hayes, P. C. (2000). Animal models of fulminant hepatic failure: A critical evaluation. Liver Transplantation, 6, 21–31.
  37. Nicholls, A. W., Mortishire-Smith, R. J., & Nicholson, J. K. (2003). NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chemical Research in Toxicology, 16, 1395–1404. · DOI
  38. Nicholson, J. K., & Wilson, I. D. (2003). Opinion: Understanding ‘global’ systems biology: Metabonomics and the continuum of metabolism. Nature Reviews Drug Discovery, 2, 668–676. · DOI
  39. Nordstrom, A., O’Maille, G., Qin, C., & Siuzdak, G. (2006). Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: Quantitative analysis of endogenous and exogenous metabolites in human serum. Analytical Chemistry, 78, 3289–3295. · DOI
  40. Novakova, L., Solichova, D., & Solich, P. (2006). Advantages of ultra performance liquid chromatography over high-performance liquid chromatography: Comparison of different analytical approaches during analysis of diclofenac gel. Journal of Separation Science, 29, 2433–2443. · DOI
  41. Ozer, J., Ratner, M., Shaw, M., Bailey, W., & Schomaker, S. (2008). The current state of serum biomarkers of hepatotoxicity. Toxicology, 245, 194–205. · DOI
  42. Petkova, D. H., Momchilova, A. B., Markovska, T. T., & Koumanov, K. S. (1987). d-galactosamine induced changes in rat liver plasma membranes lipid composition and some enzyme activities. The International Journal of Biochemistry, 19, 289–291. · DOI
  43. Schauer, N., & Fernie, A. R. (2006). Plant metabolomics: Towards biological function and mechanism. Trends in Plant Science, 11, 508–516. · DOI
  44. Stramentinoli, G., Gualano, M., & Ideo, G. (1978). Protective role of S-adenosyl-l-methionine on liver injury induced by d-galactosamine in rats. Biochemical Pharmacology, 27, 1431–1433. · DOI
  45. Tosti, E., Dahl, L., Endresen, M. J., & Henriksen, T. (1999). Endothelial degradation of extracellular lyso-phosphatidylcholine. Scandinavian Journal of Clinical and Laboratory Investigation, 59, 249–257. · DOI
  46. Tunon, M. J., Alvarez, M., Culebras, J. M., & Gonzalez-Gallego, J. (2009). An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World Journal of Gastroenterology, 15, 3086–3098. · DOI
  47. Ulrich, R. G. (2007). Idiosyncratic toxicity: A convergence of risk factors. Annual Review of Medicine, 58, 17–34. · DOI
  48. Yovchev, M. I., Grozdanov, P. N., Zhou, H., Racherla, H., Guha, C., & Dabeva, M. D. (2008). Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology, 47, 636–647. · DOI
  49. Zhang, Q., Wang, G., Du, Y., Zhu, L., & Jiye, A. (2007). GC/MS analysis of the rat urine for metabonomic research. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 854, 20–25. · DOI

Cited by

Sorted by citations

See all 69

Metadata

Authors
Gonzalez, E., van Liempd, S., Conde-Vancells, J., Gutierrez-de Juan, V., Perez-Cormenzana, M., Mayo, R., Berisa, A., Alonso, C., Marquez, C. A., Barr, J., Lu, S. C., Mato, J. M., & Falcon-Perez, J. M.
Venue
Metabolomics
Publisher
Springer Science and Business Media LLC
Published
2011-07-14
Volume
8
Issue
6
Pages
997-1011
ISSN
  • 1573-3882
  • 1573-3890
DOI
10.1007/s11306-011-0329-9
PMC
PMC3490499
Cited by
69
References
1
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review